Literature DB >> 25381428

Renal allograft rejection: pieces of the puzzle.

Lorraine Racusen1, Carmen Lefaucheur2.   

Abstract

Keywords:  endarteritis; endothelial antigen; rejection

Mesh：

Year:  2014        PMID： 25381428      PMCID： PMC4413772          DOI： 10.1681/ASN.2014090932

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  10 in total

1.  Donor-specific antibodies accelerate arteriosclerosis after kidney transplantation.

Authors:  Gary S Hill; Dominique Nochy; Patrick Bruneval; J P Duong van Huyen; Denis Glotz; Caroline Suberbielle; Julien Zuber; Dany Anglicheau; Jean-Philippe Empana; Christophe Legendre; Alexandre Loupy
Journal:  J Am Soc Nephrol       Date:  2011-04-14       Impact factor: 10.121

2.  Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining.

Authors:  Banu Sis; Gian S Jhangri; Sakarn Bunnag; Kara Allanach; Bruce Kaplan; Philip F Halloran
Journal:  Am J Transplant       Date:  2009-07-22       Impact factor: 8.086

3.  Endothelial cell antibodies associated with novel targets and increased rejection.

Authors:  Annette M Jackson; Tara K Sigdel; Marianne Delville; Szu-Chuan Hsieh; Hong Dai; Serena Bagnasco; Robert A Montgomery; Minnie M Sarwal
Journal:  J Am Soc Nephrol       Date:  2014-11-07       Impact factor: 10.121

Review 4.  The Banff classification revisited.

Authors:  Kim Solez; Lorraine C Racusen
Journal:  Kidney Int       Date:  2012-12-12       Impact factor: 10.612

5.  Isolated endarteritis and kidney transplant survival: a multicenter collaborative study.

Authors:  Banu Sis; Serena M Bagnasco; Lynn D Cornell; Parmjeet Randhawa; Mark Haas; Belinda Lategan; Alex B Magil; Andrew M Herzenberg; Ian W Gibson; Michael Kuperman; Kotaro Sasaki; Edward S Kraus
Journal:  J Am Soc Nephrol       Date:  2014-11-07       Impact factor: 10.121

6.  Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.

Authors:  B Sis; M Mengel; M Haas; R B Colvin; P F Halloran; L C Racusen; K Solez; W M Baldwin; E R Bracamonte; V Broecker; F Cosio; A J Demetris; C Drachenberg; G Einecke; J Gloor; D Glotz; E Kraus; C Legendre; H Liapis; R B Mannon; B J Nankivell; V Nickeleit; J C Papadimitriou; P Randhawa; H Regele; K Renaudin; E R Rodriguez; D Seron; S Seshan; M Suthanthiran; B A Wasowska; A Zachary; A Zeevi
Journal:  Am J Transplant       Date:  2010-01-29       Impact factor: 8.086

7.  Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies.

Authors:  M Taniguchi; L M Rebellato; J Cai; J Hopfield; K P Briley; C E Haisch; P G Catrou; P Bolin; K Parker; W T Kendrick; S A Kendrick; R C Harland; P I Terasaki
Journal:  Am J Transplant       Date:  2013-08-13       Impact factor: 8.086

8.  Antibody-mediated vascular rejection of kidney allografts: a population-based study.

Authors:  Carmen Lefaucheur; Alexandre Loupy; Dewi Vernerey; Jean-Paul Duong-Van-Huyen; Caroline Suberbielle; Dany Anglicheau; Jérôme Vérine; Thibaut Beuscart; Dominique Nochy; Patrick Bruneval; Dominique Charron; Michel Delahousse; Jean-Philippe Empana; Gary S Hill; Denis Glotz; Christophe Legendre; Xavier Jouven
Journal:  Lancet       Date:  2012-11-23       Impact factor: 79.321

9.  Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.

Authors:  M Haas; B Sis; L C Racusen; K Solez; D Glotz; R B Colvin; M C R Castro; D S R David; E David-Neto; S M Bagnasco; L C Cendales; L D Cornell; A J Demetris; C B Drachenberg; C F Farver; A B Farris; I W Gibson; E Kraus; H Liapis; A Loupy; V Nickeleit; P Randhawa; E R Rodriguez; D Rush; R N Smith; C D Tan; W D Wallace; M Mengel
Journal:  Am J Transplant       Date:  2014-02       Impact factor: 8.086

Review 10.  Transplant glomerulopathy: the interaction of HLA antibodies and endothelium.

Authors:  William Hanf; Claudine S Bonder; P Toby H Coates
Journal:  J Immunol Res       Date:  2014-03-09       Impact factor: 4.818
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.